Comments
Loading...
Kestra Medical Techs Analyst Ratings and Price Targets | NASDAQ:KMTS | Benzinga
Kestra Medical Technologies Ltd has a consensus price target of $27 based on the ratings of 5 analysts. The high is $29 issued by Wolfe Research on March 31, 2025. The low is $23 issued by Goldman Sachs on April 16, 2025. The 3 most-recent analyst ratings were released by Goldman Sachs, Wolfe Research, and Wells Fargo on April 16, 2025, March 31, 2025, and March 31, 2025, respectively. With an average price target of $26.67 between Goldman Sachs, Wolfe Research, and Wells Fargo, there's an implied 17.47% upside for Kestra Medical Technologies Ltd from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Goldman Sachs
Wolfe Research
Wells Fargo
Stifel
Piper Sandler
1calculated from analyst ratings
Analyst Ratings for Kestra Medical Techs
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 04/16/2025 | Buy Now | 1.32% | Goldman Sachs | David Roman42% | $24 → $23 | Maintains | Neutral | Get Alert |
| 03/31/2025 | Buy Now | 27.75% | Wolfe Research | Mike Polark56% | → $29 | Initiates | → Outperform | Get Alert |
| 03/31/2025 | Buy Now | 23.35% | Wells Fargo | Larry Biegelsen68% | → $28 | Initiates | → Overweight | Get Alert |
| 03/31/2025 | Buy Now | 23.35% | Stifel | Rick Wise74% | → $28 | Initiates | → Buy | Get Alert |
| 03/31/2025 | Buy Now | 5.73% | Goldman Sachs | David Roman42% | → $24 | Initiates | → Neutral | Get Alert |
| 03/31/2025 | Buy Now | 18.94% | Piper Sandler | Matt O'Brien53% | → $27 | Initiates | → Overweight | Get Alert |
FAQ
What is the target price for Kestra Medical Techs (KMTS) stock?
The latest price target for Kestra Medical Techs (NASDAQ:KMTS) was reported by Goldman Sachs on April 16, 2025. The analyst firm set a price target for $23.00 expecting KMTS to rise to within 12 months (a possible 1.32% upside). 6 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Kestra Medical Techs (KMTS)?
The latest analyst rating for Kestra Medical Techs (NASDAQ:KMTS) was provided by Goldman Sachs, and Kestra Medical Techs maintained their neutral rating.
When was the last upgrade for Kestra Medical Techs (KMTS)?
There is no last upgrade for Kestra Medical Techs
When was the last downgrade for Kestra Medical Techs (KMTS)?
There is no last downgrade for Kestra Medical Techs.
When is the next analyst rating going to be posted or updated for Kestra Medical Techs (KMTS)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Kestra Medical Techs, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Kestra Medical Techs was filed on April 16, 2025 so you should expect the next rating to be made available sometime around April 16, 2026.
Is the Analyst Rating Kestra Medical Techs (KMTS) correct?
While ratings are subjective and will change, the latest Kestra Medical Techs (KMTS) rating was a maintained with a price target of $24.00 to $23.00. The current price Kestra Medical Techs (KMTS) is trading at is $22.70, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
